Roles of phosphatidylinositol-3-kinases signaling pathway in inflammation-related cancer: Impact of rs10889677 variant and buparlisib in colitis-associated cancer

Table 1 Clinical and demographic details of the recruited patients

	CRC (n = 15)	CAC (n = 7)	UC (n = 10)
Median age (range)	63 (39-67)	58 (20-71)	65 (52-69)
Race
Malay	11	2	5
Chinese	4	2	3
Indian	-	3	2
Gender
Male	9	3	4
Female	6	4	6
Smoking status
Smoker/Ex-smoker	2	1	-
Non-smoker	13	6	10
Stage1
I	2	1	Not applicable
II	-	-
III	7	4
Adenocarcinoma types1
Poorly differentiated	-	1	Not applicable
Moderately differentiated	7	1
Well differentiated	1	3
Mayo score (range)1	Not applicable	Data unavailable	1-3
Geboes score (range)1	Not applicable	Data unavailable	2A.1-2A.2
Presentation	Rectal bleeding	Rectal bleeding, abdominal pain, severe diarrhea	Diarrhea, loss of appetite

¹Some data are unavailable.

All data are expressed as n except where indicated in the table. UC: Ulcerative colitis; CRC: Colorectal cancer; CAC: Colitis-associated cancer.